IFNG and neoplasm: IL-2/CD40 reduced CD25 (Figure 10C) and IFN-γ (Figure 10C) in tumor-associated CD4+ T cells in both age groups alongside reductions in the regulatory markers CD73 (Figure 10C) and CTLA-4 (Figure 10D).